Patient-Led Research Fund Webinar Agenda
PDF download
10:00 am – 2:00 pm PT | 1:00 pm – 5:00 pm ET
Zoom Link: https://us02web.zoom.us/webinar/register/WN_FlN9_eVjRdmKFJ9WnlpMkw#/registration
| Presenter | Time (ET) | Patient Rep | Title |
| Gina Assaf & Hannah Davis | 1:00 p.m | Welcome & Introductions & Short Process Talk | |
| Braeden Charlton, PhD | 1:15 p.m | Skeletal Muscle Abnormalities in Long COVID | |
| Caroline Dalton, PhD | 1:30 p.m | Michael Natt | Fibrinaloid microclot quantification in plasma from people with Long COVID and ME/CFS |
| Liisa Selin, MD, PhD | 1:45 p.m | Megan Fitzgerald, PhD, Rivka Solomon | Altered T cell responses in Long COVID (PASC) and ME/CFS |
| David Esteban, PhD | 2:00 p.m | Tess Falor, PhD | Alterations in tryptophan metabolism in the gut microbiome of people with ME/CFS and Long COVID |
| Megan Fitzgerald, PhD | 2:15 p.m | Nothing for us without us: aligning research funding with patient priorities | |
| 2:30 p.m | Break (10 Minutes) | ||
| Roshan Kumar, PhD | 2:40 p.m | Rivka Solomon | T cell dysregulation revealed by single-cell profiling of ME/CFS and Long COVID patients |
| Per Sjögren, MD& Bo C Bertilson, MD | 2:55 p.m | Tess Falor, PhD | Surgery for foraminal stenosis in ME/CFS |
| Wenzhong Xiao, PhD | 3:10 p.m | Becky Taurog, PhD, Chimére L. Sweeney | Systems Biology Approaches to Uncovering Disease Mechanism and Drug Repurposing for Long COVID |
| Alain Moreau, PhD | 3:25 p.m | Epigenomics of Long COVID: Insights, Breakthroughs, and Emerging Hope. | |
| 3:40 p.m | Break (10 Minutes) | ||
| Janet Mullington, PhD | 3:50 p.m | Letícia Soares, PhD | Characterizing non-restorative sleep in post-viral disease to advance intervention innovations |
| Michael Peluso, MD | 4:05 p.m | Anisha Sekar | Monoclonal antibodies in Long COVID: what needs to happen next |
| Moderated by Julia Moore Vogel with Liisa Selin, Janet Mullington, & Roshan Kumar (research grantees), Anisha Sekar (patient rep), and Hannah Davis (PLRF admin) | 4:20 p.m | Advancing Long COVID Research: The Power of Patient-Centered Science and Patient-Driven Funding | |
| Hannah Davis | 4:35 p.m | – | Closing Remarks |